10% of reproductive women are effected by endometriosis and 10-13% struggle with PCOS. The hormone replacement industry was estimated to be 18.7 USD in 2022.

The "one size fits all" approach is ineffective, causes headaches, mood changes and many more problems to women.

Fempatch aims to create aptamer-based biosensors that measure concentration of estrogen and progesterone in blood at the comfort of your own home to model your unique cycle.

We were part of the BioIncubate program in 2024 and supported by the SPH Biolab.